Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets express concern over cheap wormer promotion
"It is exceedingly disappointing to see de-wormers being advertised in this way" - David Rendle, BEVA.
Retailer accused of putting 'short-term profits above equine welfare'.

The British Equine Veterinary Association (BEVA) has expressed concern over a ‘potentially damaging’ online promotion advertising cheap wormers for horses.

The well-known retailer advertised 'horse wormers from £4.33', and the Association fears this could lead horse owners to make poor judgments on equine worm management based primarily on cost rather than clinical need. 

The subject has been the subject of debate in the equine press, with Horse & Hound recently publishing an item featuring a statement from BEVA. 

"It is exceedingly disappointing to see de-wormers being advertised in this way by companies who are putting their short-term profits above equine welfare and the long-term effectiveness of these products,” commented David Rendle, chair of BEVA’s Health and Medicines Committee.

“We now have resistance to every class of de-wormer and it is grossly irresponsible to be promoting these products based on their low cost. These products should only be used where there has been careful consideration of the risk of clinical disease and appropriate diagnostic testing.

“Antibacterial drugs would never be advertised in this way, so why is it acceptable for de-wormers? Resistant worms pose a far more immediate threat to equine welfare than resistant bacteria.  Is the equine industry ever going to wake up to the threat that resistant parasites pose to equine welfare and the future viability of the industry?”

A spokesperson for the retailer expressed regret for the promotion's content and pledged to review the firm's communications to ensure appropriate guidance is provided.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.